Deep-pocketed investors have adopted a bullish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HIMS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Hims & Hers Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $313,116, and 4 are calls, amounting to $184,794.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $14.0 to $21.0 for Hims & Hers Health over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Hims & Hers Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims & Hers Health's whale trades within a strike price range from $14.0 to $21.0 in the last 30 days.
Hims & Hers Health 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | PUT | SWEEP | BEARISH | 01/17/25 | $1.5 | $1.45 | $1.5 | $14.00 | $104.7K | 790 | 26 |
| HIMS | PUT | SWEEP | BULLISH | 07/19/24 | $0.25 | $0.0 | $0.25 | $20.50 | $78.2K | 454 | 15 |
| HIMS | PUT | SWEEP | BEARISH | 07/19/24 | $0.25 | $0.15 | $0.25 | $20.50 | $66.8K | 454 | 7.4K |
| HIMS | CALL | SWEEP | BEARISH | 08/16/24 | $2.65 | $2.5 | $2.55 | $21.00 | $60.8K | 1.7K | 6 |
| HIMS | CALL | TRADE | NEUTRAL | 07/19/24 | $2.5 | $2.3 | $2.39 | $18.00 | $45.8K | 5.5K | 106 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Where Is Hims & Hers Health Standing Right Now?
- Currently trading with a volume of 8,346,592, the HIMS's price is down by -0.26%, now at $20.32.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 17 days.
Professional Analyst Ratings for Hims & Hers Health
4 market experts have recently issued ratings for this stock, with a consensus target price of $22.25.
- An analyst from Jefferies has decided to maintain their Hold rating on Hims & Hers Health, which currently sits at a price target of $23.
- An analyst from Piper Sandler has decided to maintain their Neutral rating on Hims & Hers Health, which currently sits at a price target of $18.
- An analyst from Truist Securities has decided to maintain their Hold rating on Hims & Hers Health, which currently sits at a price target of $23.
- An analyst from TD Cowen persists with their Buy rating on Hims & Hers Health, maintaining a target price of $25.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Hims & Hers Health, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
